Editorial: Challenges to opioid use disorders during COVID-19
COVID-19 brings an opportunity to learn as well as a responsibility to prevent and treat. Clinical scientists must learn from early experience and communicate to the global community as well as adapt local health care to emergencies such as the COVID-19 epidemic. This adaptation to COVID-19 must include paying attention to pre-existing medical and mental disorders and understanding the interrelationship of these comorbid disorders in drug-dependent populations.
Read the editorial here